2023 Q3 Form 10-Q Financial Statement
#000149315223028437 Filed on August 14, 2023
Income Statement
Concept | 2023 Q3 | 2023 Q2 |
---|---|---|
Revenue | $974.9K | $315.9K |
YoY Change | 314.28% | 116.17% |
Cost Of Revenue | $580.0K | $235.7K |
YoY Change | 431.54% | 201.22% |
Gross Profit | $390.0K | $80.19K |
YoY Change | 209.02% | 18.13% |
Gross Profit Margin | 40.0% | 25.38% |
Selling, General & Admin | $1.257M | $2.043M |
YoY Change | -49.24% | -20.18% |
% of Gross Profit | 322.32% | 2547.21% |
Research & Development | $2.668K | $83.85K |
YoY Change | -98.48% | -56.04% |
% of Gross Profit | 0.68% | 104.56% |
Depreciation & Amortization | $20.50K | $19.71K |
YoY Change | 77.89% | 41.31% |
% of Gross Profit | 5.26% | 24.57% |
Operating Expenses | $1.861M | $2.382M |
YoY Change | -29.81% | -13.38% |
Operating Profit | -$886.3K | -$2.066M |
YoY Change | -64.91% | -22.96% |
Interest Expense | $352.1K | $175.2K |
YoY Change | 19893.47% | 171656.86% |
% of Operating Profit | ||
Other Income/Expense, Net | -$360.3K | -$171.7K |
YoY Change | 1388.39% | 44.36% |
Pretax Income | -$1.247M | -$2.238M |
YoY Change | -51.11% | -20.11% |
Income Tax | $1.886K | $2.865K |
% Of Pretax Income | ||
Net Earnings | -$1.248M | -$2.241M |
YoY Change | -51.03% | -20.03% |
Net Earnings / Revenue | -128.06% | -709.24% |
Basic Earnings Per Share | -$0.70 | -$3.06 |
Diluted Earnings Per Share | -$0.70 | -$3.06 |
COMMON SHARES | ||
Basic Shares Outstanding | 2.450M shares | 13.97M shares |
Diluted Shares Outstanding | 1.777M shares | 732.3K shares |
Balance Sheet
Concept | 2023 Q3 | 2023 Q2 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $1.060M | $112.5K |
YoY Change | 271.02% | -94.27% |
Cash & Equivalents | $1.056M | $112.5K |
Short-Term Investments | ||
Other Short-Term Assets | $370.0K | $374.7K |
YoY Change | 21.25% | 51.29% |
Inventory | $254.2K | $280.0K |
Prepaid Expenses | ||
Receivables | $116.8K | $74.91K |
Other Receivables | $0.00 | $0.00 |
Total Short-Term Assets | $1.792M | $842.1K |
YoY Change | 90.15% | -66.95% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $772.4K | $659.4K |
YoY Change | 69.27% | 39.4% |
Goodwill | $8.225M | |
YoY Change | ||
Intangibles | $1.750M | |
YoY Change | 1218.97% | |
Long-Term Investments | $1.080M | $1.132M |
YoY Change | -15.71% | -15.98% |
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $17.68M | $5.797M |
YoY Change | 373.35% | 49.53% |
TOTAL ASSETS | ||
Total Short-Term Assets | $1.792M | $842.1K |
Total Long-Term Assets | $17.68M | $5.797M |
Total Assets | $19.48M | $6.639M |
YoY Change | 316.31% | 3.33% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $1.850M | $1.845M |
YoY Change | 168.29% | 295.01% |
Accrued Expenses | $980.0K | $1.429M |
YoY Change | 12.28% | 94.34% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $880.0K | $770.0K |
YoY Change | ||
Long-Term Debt Due | $820.0K | $263.9K |
YoY Change | ||
Total Short-Term Liabilities | $4.884M | $4.469M |
YoY Change | 194.05% | 249.18% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $1.100M | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $13.12M | $3.873M |
YoY Change | 658.86% | 116.7% |
Total Long-Term Liabilities | $14.22M | $3.873M |
YoY Change | 722.48% | 116.7% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $4.884M | $4.469M |
Total Long-Term Liabilities | $14.22M | $3.873M |
Total Liabilities | $19.10M | $8.344M |
YoY Change | 463.35% | 171.94% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$55.80M | -$54.60M |
YoY Change | 18.72% | 22.7% |
Common Stock | $56.20M | $52.87M |
YoY Change | 16.34% | 4358467.93% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $372.8K | -$1.705M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $19.48M | $6.639M |
YoY Change | 316.31% | 3.33% |
Cashflow Statement
Concept | 2023 Q3 | 2023 Q2 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$1.248M | -$2.241M |
YoY Change | -51.03% | -20.03% |
Depreciation, Depletion And Amortization | $20.50K | $19.71K |
YoY Change | 77.89% | 41.31% |
Cash From Operating Activities | -$1.250M | -$1.644M |
YoY Change | -24.16% | -12.2% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $110.0K | $261.5K |
YoY Change | -3766.67% | -8024.55% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | -$2.150M | $0.00 |
YoY Change | -100.0% | |
Cash From Investing Activities | -$2.260M | -$261.5K |
YoY Change | 74983.06% | 5236.73% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 4.440M | -169.9K |
YoY Change | -17719.05% | |
NET CHANGE | ||
Cash From Operating Activities | -1.250M | -1.644M |
Cash From Investing Activities | -2.260M | -261.5K |
Cash From Financing Activities | 4.440M | -169.9K |
Net Change In Cash | 930.0K | -2.076M |
YoY Change | -155.47% | 10.55% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$1.250M | -$1.644M |
Capital Expenditures | $110.0K | $261.5K |
Free Cash Flow | -$1.360M | -$1.906M |
YoY Change | -17.34% | 1.95% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001417926 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
CY2023Q2 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
usd | |
us-gaap |
Investment Income Net
InvestmentIncomeNet
|
usd | ||
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
usd | ||
us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
usd | ||
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
usd | ||
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
usd | ||
INVO |
Proceeds From Option Exercises
ProceedsFromOptionExercises
|
usd | ||
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
usd | ||
us-gaap |
Interest Paid Net
InterestPaidNet
|
usd | ||
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
usd | ||
INVO |
Fair Value Of Warrants Issued With Debt
FairValueOfWarrantsIssuedWithDebt
|
usd | ||
INVO |
Initial Rou Asset And Lease Liability
InitialRouAssetAndLeaseLiability
|
usd | ||
CY2023Q2 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
usd | |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
usd | ||
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
usd | |
INVO |
Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodTotalIntrinsicValue
|
usd | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
usd | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue
|
|||
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
usd | |
CY2023Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
usd | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
pure | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
pure | ||
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
usd | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
usd | |
CY2022Q4 | INVO |
Share Based Compensation Arrangement By Share Based Payment Award Non Options Aggregate Intrinsic Value Warrants Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsAggregateIntrinsicValueWarrantsOutstanding
|
usd | |
INVO |
Share Based Compensation Arrangement By Share Based Payment Award Non Options Aggregate Intrinsic Value Warrants Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsAggregateIntrinsicValueWarrantsGranted
|
usd | ||
INVO |
Share Based Compensation Arrangement By Share Based Payment Award Non Options Aggregate Intrinsic Value Warrants Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsAggregateIntrinsicValueWarrantsExercised
|
usd | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
|
shares | ||
INVO |
Share Based Compensation Arrangements By Share Based Payment Award Non Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
|||
INVO |
Share Based Compensation Arrangement By Share Based Payment Award Non Options Aggregate Intrinsic Value Warrants Forfeiture
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsAggregateIntrinsicValueWarrantsForfeiture
|
usd | ||
CY2023Q2 | INVO |
Share Based Compensation Arrangement By Share Based Payment Award Non Options Aggregate Intrinsic Value Warrants Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsAggregateIntrinsicValueWarrantsOutstanding
|
usd | |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-06-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-39701 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
INVO Bioscience, Inc. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
20-4036208 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
5582 Broadcast Court | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Sarasota | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
FL | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
34240 | ||
dei |
City Area Code
CityAreaCode
|
(978) | ||
dei |
Local Phone Number
LocalPhoneNumber
|
878-9505 | ||
dei |
Security12b Title
Security12bTitle
|
Common Stock, $0.0001 par value per share | ||
dei |
Trading Symbol
TradingSymbol
|
INVO | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2023Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
2449662 | shares |
CY2023Q2 | us-gaap |
Cash
Cash
|
112485 | usd |
CY2022Q4 | us-gaap |
Cash
Cash
|
90135 | usd |
CY2023Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
74908 | usd |
CY2022Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
77149 | usd |
CY2023Q2 | us-gaap |
Inventory Net
InventoryNet
|
280018 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
263602 | usd |
CY2023Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
374714 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
190201 | usd |
CY2023Q2 | us-gaap |
Assets Current
AssetsCurrent
|
842125 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
621087 | usd |
CY2023Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
659442 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
436729 | usd |
CY2023Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
4004962 | usd |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
1808034 | usd |
CY2023Q2 | us-gaap |
Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
|
1132365 | usd |
CY2022Q4 | us-gaap |
Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
|
1237865 | usd |
CY2023Q2 | us-gaap |
Assets
Assets
|
6638894 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
4103715 | usd |
CY2023Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
1844629 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
1349038 | usd |
CY2023Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1202420 | usd |
CY2022Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
946262 | usd |
CY2023Q2 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
161187 | usd |
CY2022Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
119876 | usd |
CY2023Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
227026 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
231604 | usd |
CY2023Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4469150 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3409424 | usd |
CY2023Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
3873289 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
1669954 | usd |
CY2023Q2 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
1949 | usd |
CY2022Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
1949 | usd |
CY2023Q2 | us-gaap |
Liabilities
Liabilities
|
8344388 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
5081327 | usd |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
6250000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
6250000 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
826886 | shares |
CY2023Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
826886 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
608611 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
608611 | shares |
CY2023Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
83 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
61 | usd |
CY2023Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
52869346 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
48805860 | usd |
CY2023Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-54574923 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-49783533 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1705494 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-977612 | usd |
CY2023Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
6638894 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
4103715 | usd |
CY2023Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
315902 | usd |
CY2022Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
146135 | usd |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
663927 | usd | |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
308733 | usd | |
CY2023Q2 | INVO |
Costs Of Revenue
CostsOfRevenue
|
235714 | usd |
CY2022Q2 | INVO |
Costs Of Revenue
CostsOfRevenue
|
170526 | usd |
INVO |
Costs Of Revenue
CostsOfRevenue
|
466719 | usd | |
INVO |
Costs Of Revenue
CostsOfRevenue
|
367207 | usd | |
CY2023Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
2042609 | usd |
CY2022Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
2444586 | usd |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
4373443 | usd | |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
4991714 | usd | |
CY2023Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
83850 | usd |
CY2022Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
190761 | usd |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
157370 | usd | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
294941 | usd | |
CY2023Q2 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
19705 | usd |
CY2022Q2 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
22083 | usd |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
38792 | usd | |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
37630 | usd | |
CY2023Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
2381879 | usd |
CY2022Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
2827956 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
5036324 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
5691492 | usd | |
CY2023Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2065977 | usd |
CY2022Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2681821 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4372397 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5382759 | usd | |
CY2023Q2 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
3788 | usd |
CY2022Q2 | us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-117978 | usd |
us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-23947 | usd | |
us-gaap |
Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
|
-189095 | usd | |
CY2022Q2 | us-gaap |
Investment Income Net
InvestmentIncomeNet
|
48 | usd |
us-gaap |
Investment Income Net
InvestmentIncomeNet
|
273 | usd | |
CY2023Q2 | us-gaap |
Interest Expense
InterestExpense
|
175192 | usd |
CY2022Q2 | us-gaap |
Interest Expense
InterestExpense
|
102 | usd |
us-gaap |
Interest Expense
InterestExpense
|
391781 | usd | |
us-gaap |
Interest Expense
InterestExpense
|
1558 | usd | |
CY2023Q2 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-265 | usd |
CY2022Q2 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-888 | usd |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-400 | usd | |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-1914 | usd | |
CY2023Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-171669 | usd |
CY2022Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-118920 | usd |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-416128 | usd | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-192294 | usd | |
CY2023Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-2237646 | usd |
CY2022Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-2800741 | usd |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-4788525 | usd | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-5575053 | usd | |
CY2023Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2865 | usd |
CY2022Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
800 | usd |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2865 | usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
800 | usd | |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2240511 | usd |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2801541 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-4791390 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-5575853 | usd | |
CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-3.06 | |
CY2022Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-4.62 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-7.07 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-9.23 | ||
CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-3.06 | |
CY2022Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-4.62 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-7.07 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-9.23 | ||
CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
732255 | shares |
CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
605760 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
677684 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
604123 | shares | |
CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
732255 | shares |
CY2022Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
605760 | shares |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
677684 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
604123 | shares | |
CY2021Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
7310680 | usd |
us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
328548 | usd | |
us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
116766 | usd | |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
315000 | usd | |
us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
861284 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-5575853 | usd | |
CY2022Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
3356425 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-977612 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-977612 | usd |
us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
51565 | usd | |
us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
244176 | usd | |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
2728938 | usd | |
INVO |
Stock Issued During Period Value New Issues With Notes Payable
StockIssuedDuringPeriodValueNewIssuesWithNotesPayable
|
56314 | usd | |
us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
2375 | usd | |
us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
652750 | usd | |
us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
327390 | usd | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-9.23 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-4791390 | usd | |
CY2023Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-1705494 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-1705494 | usd |
us-gaap |
Profit Loss
ProfitLoss
|
-4791390 | usd | |
us-gaap |
Profit Loss
ProfitLoss
|
-5575853 | usd | |
INVO |
Noncash Stock Compensation Issued For Services
NoncashStockCompensationIssuedForServices
|
244176 | usd | |
INVO |
Noncash Stock Compensation Issued For Services
NoncashStockCompensationIssuedForServices
|
116766 | usd | |
us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
51565 | usd | |
us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
328548 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
652750 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
861284 | usd | |
INVO |
Noncash Compensation For Services
NoncashCompensationForServices
|
90000 | usd | |
INVO |
Noncash Compensation For Services
NoncashCompensationForServices
|
30000 | usd | |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
301098 | usd | |
INVO |
Loss From Equity Method Investments
LossFromEquityMethodInvestments
|
23947 | usd | |
INVO |
Loss From Equity Method Investments
LossFromEquityMethodInvestments
|
189095 | usd | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
38792 | usd | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
37629 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-2241 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
6015 | usd | |
us-gaap |
Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
|
16416 | usd | |
us-gaap |
Increase Decrease In Interest And Dividends Receivable
IncreaseDecreaseInInterestAndDividendsReceivable
|
-5777 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
184513 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-35069 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
432654 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
23553 | usd | |
us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
256158 | usd | |
us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-72885 | usd | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
41311 | usd | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
71457 | usd | |
us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
1829 | usd | |
us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
4655 | usd | |
us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
62938 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2792860 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3950920 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
261505 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
8338 | usd | |
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
1517 | usd | |
INVO |
Investment In Joint Ventures
InvestmentInJointVentures
|
8447 | usd | |
INVO |
Investment In Joint Ventures
InvestmentInJointVentures
|
76937 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-269952 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-86792 | usd | |
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
714000 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
2728938 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
315000 | usd | |
INVO |
Proceeds From Option Exercises
ProceedsFromOptionExercises
|
2375 | usd | |
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
360151 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
3085162 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
315000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
22350 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-3722712 | usd | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
90135 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
5684871 | usd |
CY2023Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
112485 | usd |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
1962159 | usd |
us-gaap |
Interest Paid Net
InterestPaidNet
|
5720 | usd | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
2847 | usd | |
INVO |
Fair Value Of Warrants Issued With Debt
FairValueOfWarrantsIssuedWithDebt
|
327390 | usd | |
INVO |
Initial Rou Asset And Lease Liability
InitialRouAssetAndLeaseLiability
|
2312892 | usd | |
us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | segment | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_84B_eus-gaap--UseOfEstimates_zf6QDr1PJmna" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_867_z3ZkAJgJygpj">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | ||
CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-3.06 | |
CY2023Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-3.06 | |
CY2022Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-4.62 | |
CY2022Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-4.62 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-7.07 | ||
us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | usd | |
us-gaap |
Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
|
0 | usd | |
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p id="xdx_84B_eus-gaap--ConcentrationRiskCreditRisk_z483iLU1Vrg8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_864_zI6ocnaku4bf">Concentration of Credit Risk</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash includes amounts deposited in financial institutions in excess of insurable Federal Deposit Insurance Corporation (“FDIC”) limits. As of June 30, 2023, the Company did not have cash balances in excess of FDIC limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-7.07 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-9.23 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-9.23 | ||
CY2023Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-3.06 | |
CY2022Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-4.62 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-7.07 | ||
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2240511 | usd |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2801541 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-4791390 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-5575853 | usd | |
CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
732255 | shares |
CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
732255 | shares |
CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
605760 | shares |
CY2022Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
605760 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
677684 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
677684 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
604123 | shares | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
604123 | shares | |
CY2023Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
732255 | shares |
CY2023Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
732255 | shares |
CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
605760 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
677684 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
604123 | shares | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
524526 | shares | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
87488 | shares | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-4800000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-5600000 | usd | |
CY2023Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-54600000 | usd |
INVO |
Net Income Loss Related To Non Cash Expenses
NetIncomeLossRelatedToNonCashExpenses
|
1400000 | usd | |
INVO |
Net Income Loss Related To Non Cash Expenses
NetIncomeLossRelatedToNonCashExpenses
|
1600000 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
2700000 | usd | |
CY2023Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
us-gaap |
Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
|
700000 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
300000 | usd | |
CY2021Q2 | us-gaap |
Variable Interest Entity Ownership Percentage
VariableInterestEntityOwnershipPercentage
|
1.50 | pure |
INVO |
Investment In Unconsolidated Variable Interest Entities
InvestmentInUnconsolidatedVariableInterestEntities
|
1132365 | usd | |
CY2022 | INVO |
Investment In Unconsolidated Variable Interest Entities
InvestmentInUnconsolidatedVariableInterestEntities
|
1237865 | usd |
CY2022Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
68723 | usd |
CY2023Q2 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
217273 | usd |
CY2022Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
194879 | usd |
CY2023Q2 | us-gaap |
Inventory Net
InventoryNet
|
280018 | usd |
CY2022Q4 | us-gaap |
Inventory Net
InventoryNet
|
263602 | usd |
CY2023Q2 | INVO |
Earning From Unconsolidated Variable Interest Entities
EarningFromUnconsolidatedVariableInterestEntities
|
3788 | usd |
CY2022Q2 | INVO |
Earning From Unconsolidated Variable Interest Entities
EarningFromUnconsolidatedVariableInterestEntities
|
-117978 | usd |
INVO |
Earning From Unconsolidated Variable Interest Entities
EarningFromUnconsolidatedVariableInterestEntities
|
-23947 | usd | |
INVO |
Earning From Unconsolidated Variable Interest Entities
EarningFromUnconsolidatedVariableInterestEntities
|
-189095 | usd | |
CY2023Q2 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
62745 | usd |
CY2023Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
192059 | usd |
CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
153267 | usd |
CY2023Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
659442 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
436729 | usd |
CY2023Q2 | us-gaap |
Depreciation
Depreciation
|
19705 | usd |
CY2022Q2 | us-gaap |
Depreciation
Depreciation
|
21630 | usd |
us-gaap |
Depreciation
Depreciation
|
38792 | usd | |
us-gaap |
Depreciation
Depreciation
|
36725 | usd | |
CY2022Q2 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
452 | usd |
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
904 | usd | |
CY2023Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
4004962 | usd |
CY2023Q2 | INVO |
Right Of Use Assets
RightOfUseAssets
|
4004962 | usd |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
1.132 | pure | |
CY2023Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
227026 | usd |
CY2023Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
3873289 | usd |
CY2023Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
4100315 | usd |
CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
156465 | usd |
CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
392869 | usd |
CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
392688 | usd |
CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
401581 | usd |
CY2023Q2 | INVO |
Lessee Operating Lease Liability Payments Due After Year Three
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree
|
4197510 | usd |
CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
5541113 | usd |
CY2023Q2 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
1440798 | usd |
CY2023Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
4100315 | usd |
CY2023Q2 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
285961 | usd |
CY2022Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
107356 | usd |
CY2023Q2 | INVO |
Financing Fee Related Party Demand Notes Percentage
FinancingFeeRelatedPartyDemandNotesPercentage
|
0.10 | pure |
CY2023Q2 | INVO |
Annual Interest Related Party Demand Notes Percentage
AnnualInterestRelatedPartyDemandNotesPercentage
|
0.10 | pure |
CY2023Q2 | INVO |
Annual Interest Related Party Demand Notes Percentage
AnnualInterestRelatedPartyDemandNotesPercentage
|
0.10 | pure |
CY2023Q2 | INVO |
Interest Related Party Demand Debentures Percentage
InterestRelatedPartyDemandDebenturesPercentage
|
0.08 | pure |
CY2023Q2 | INVO |
Interest Related Party Demand Conversion Price
InterestRelatedPartyDemandConversionPrice
|
10.40 | |
CY2023Q2 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
285961 | usd |
CY2022Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
107356 | usd |
CY2023Q2 | us-gaap |
Notes Payable
NotesPayable
|
1033888 | usd |
CY2022Q4 | us-gaap |
Notes Payable
NotesPayable
|
762644 | usd |
CY2022Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
|
17500 | shares |
CY2022Q4 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
200000 | usd |
CY2022Q4 | us-gaap |
Debt Instrument Description
DebtInstrumentDescription
|
These notes accrue 10% annual interest accrues from the date of issuance. These notes are callable with 10 days prior written notice. At maturity, the Company agreed to pay outstanding principal, a 10% financing fee and accrued interest | |
CY2023Q1 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
410000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
410000 | usd |
CY2022Q4 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
310000 | usd |
CY2023Q2 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
12.00 | |
us-gaap |
Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
|
19375 | shares | |
CY2023Q2 | us-gaap |
Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
|
0.10 | pure |
us-gaap |
Debt Instrument Maturity Date
DebtInstrumentMaturityDate
|
2023-12-31 | ||
CY2023Q1 | us-gaap |
Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
|
0.08 | pure |
CY2023Q1 | us-gaap |
Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
|
0.08 | pure |
CY2023Q1 | us-gaap |
Share Price
SharePrice
|
10.40 | |
CY2023Q1 | us-gaap |
Share Price
SharePrice
|
10.40 | |
CY2023Q1 | INVO |
Percentage Of Debentures Outstanding
PercentageOfDebenturesOutstanding
|
0.50 | pure |
CY2023Q1 | INVO |
Percentage Of Debentures Outstanding
PercentageOfDebenturesOutstanding
|
0.50 | pure |
CY2023Q1 | us-gaap |
Sale Of Stock Description Of Transaction
SaleOfStockDescriptionOfTransaction
|
(i) in a minimum amount of not less than $25,000 and (ii) in a maximum amount of up to the lesser of (a) $750,000 or (b) 200% of the Company’s average daily trading value of the Common Stock | |
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
2375 | usd | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
64850 | shares |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
68.00 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
59048 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
7.74 | ||
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
297 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
8.00 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
2346 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
72.38 | ||
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
121255 | shares |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
2.10 | |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
71251 | shares |
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
62.42 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.036 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.0369 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.016 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.019 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
1.066 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
|
1.149 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
|
1.104 | pure | |
CY2022 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
1616401 | usd |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
|
654925 | usd | |
CY2022Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
|
25864 | shares |
CY2022Q4 | INVO |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price Warrants
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceWarrants
|
30.20 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
|
432618 | shares | |
INVO |
Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
|
12.60 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
|
115000 | shares | |
INVO |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Weighted Average Exercise Price Of Warrants Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWeightedAverageExercisePriceOfWarrantsExercised
|
0.20 | ||
CY2023Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
|
378849 | shares |
CY2023Q2 | INVO |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price Warrants
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceWarrants
|
20.41 | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2865 | usd | |
CY2023Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
2865 | usd |
CY2022Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
800 | usd |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
800 | usd | |
us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0 | pure | |
us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0 | pure |